SCHEMBL31332901

SCHEMBL31332901

O=C(NC[C@@]1(c2cccc(Cl)c2)CCO1)[C@H]1C[C@@H]1c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
SIGMAR1 Q99720 8/20 0.43
ALDH1A1 P00352 3/20 0.42
HDAC4 P56524 1/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LPAR2 Q9HBW0 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KCNQ3 O43525 1/20 0.39
KCNQ2 O43526 1/20 0.39
KCNQ4 P56696 1/20 0.39
KCNQ5 Q9NR82 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31332708 1.00 LMNA (0.48) LMNASIGMAR1ALDH1A1HDAC4MEN1
SCHEMBL31332651 0.87 DGAT2 (0.48) SIGMAR1ALDH1A1HDAC4NPC1RAB9A
SCHEMBL31332744 0.87 DGAT2 (0.48) SIGMAR1ALDH1A1HDAC4NPC1RAB9A
SCHEMBL31332611 0.86 LMNA (0.45) LMNASIGMAR1ALDH1A1HDAC4MEN1
SCHEMBL31332773 0.82 CTSL (0.42) SIGMAR1ALDH1A1HDAC4NPC1RAB9A
SCHEMBL31332721 0.82 LMNA (0.49) LMNASIGMAR1ALDH1A1HDAC4MEN1
SCHEMBL31332719 0.82 LMNA (0.47) LMNASIGMAR1ALDH1A1HDAC4MEN1
SCHEMBL31332673 0.82 LMNA (0.47) LMNASIGMAR1ALDH1A1HDAC4MEN1
SCHEMBL31332627 0.82 LMNA (0.47) LMNASIGMAR1ALDH1A1HDAC4MEN1
SCHEMBL31332777 0.81 ALDH1A1 (0.42) LMNASIGMAR1ALDH1A1HDAC4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709708-A1 NOVEL CARBOXAMIDE DERIVATIVES ANGELINI PHARMA S.P.A. (IT) 2026-03-18 EP disclosed
WO-2024233603-A1 NOVEL CARBOXAMIDE DERIVATIVES ICAGEN, LLC (US) 2024-11-14 WO disclosed